Dr. Sreeja Narayanan received her PhD from the Amrita Centre for Nanosciences and Molecular Medicine in Nanobiotechnology for her work on the design and application of polymeric core/shell nanomedicine for sequential drug delivery in breast cancer therapy. She did her postdoctoral training from the Department of Biotechnology, Cochin University of Science and Technology. She obtained her Masters in Science (Biotechnology) for the Mahatma Gandhi University and Masters in Technology (Nanomedical Science) from Amrita Vishwavidyapeetham. Presently, she is the Wellcome Trust/DBT Fellow at the Department of Biotechnology.

Research Interest
Triple-negative breast cancer (TNBC) is a clinically heterogeneous and molecularly diverse subset of breast cancer with high levels of mutations leading to large numbers of immunogenic neo-antigens that helps the tumor to escape the innate immunity surveillance. My interest is in developing biomimetic constructs for specific stimulation of the immuno-microenvironment in TNBC so as to aid improved therapy.

Awards and Honors
• Vice-Chancellor’s Letter of Appreciation for research accomplishments at CUSAT, 2020
• DBT-Wellcome Trust Early Career Award, 2020, Indo-UK Alliance, Govt. of India
• UGC-DS Kothari Postdoctoral Fellowship (2017), Govt. of India
• Prize winning poster at the International Conference on Frontiers in Nanoscience and Technology, Cochin Nano 2011
• ICMR Research Fellowship (2010-2015)
• Graduate Aptitude Test in Engineering (GATE-2007)
• 3rd position at University level for MSc-2007
• 5th position at University level for BSc-2005
• College topper (1st position) during BSc-2005

Publications/Invited Lectures
• Narayanan S, Kurian N, Bhat SG. Ultra-small pyomelanin nanogranules abiotically derived from bacteria-secreted homogentisic acid show potential applications in inflammation and cancer. BioNanoScience 2019:10, 191–203.

• Narayanan S, Mony U, Vijaykumar DK, Manzoor K, Bindhu Paul-Prasanth, Menon D. Sequential release of Epigallocatechin gallate and Paclitaxel from PLGA-Casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine 2015:6:1399-406.

• Narayanan S, Pavithran M, Viswanath A, Narayanan D, Mohan CC, Manzoor K, Nair SV, Menon D. Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: Design, synthesis, biocompatibility and pharmacokinetics. Acta biomaterialia 2014;10:2112-24.

• Narayanan S, Sathy BN, Mony U, Koyakutty M, Nair SV, Menon D. Biocompatible magnetite/gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging. ACS applied materials & interfaces 2012;4:251-60.

• Narayanan S, Prasad T, Nair IC, Jayachandran K. A novel exploitable feature of Chromobacterium violaceum: experimental evidence for Phenol degradation. Novus international journal of biotechnology and bioscience 2012; 1(3)

• Menon D, Thomas RT, Narayanan S, Maya S, Jayakumar R, Hussain F, Lakshmanan V-K, Nair SV.A novel chitosan/polyoxometalate nano-complex for anti-cancer applications. Carbohydrate Polymers 2011;84:887-893.

• Narayanan S, Binulal NS, Mony U, Manzoor K, Nair S, Menon D. Folate targeted polymeric 'green' nanotherapy for cancer. Nanotechnology 2010;21:285107.

• Narayanan S, Prasad T, Jayachandran K. Chromobacterium violaciem- a potential candidate for Biotechnological applications. Advanced Biotech (now The Scitech Journal) 2006;5,06,31-33.

• Conference Proceeding: Cancer nanomedicine: Leveraging nanotechnology to tackle cancer. Narayanan S. Proceedings of the National Seminar on Emerging trends in Genomic Research, 2019, ISBN: 978-81-935819-4-0.

• National Science Day Talk, Tackling cancer: A story about taming the ‘misbehaved, 2020, School of Pharmacy,

Amrita Vishwavidyapeetham.
• National Seminar on Emerging trends in Genomic Research, Cancer Nanomedicine: leveraging nanotechnology to tackle cancer, 2019, St. Thomas College (Autonomous), Trissur, India
Publication links:

Google Scholar https://scholar.google.co.in/citations?user=3H8Y1m8AAAAJ&hl=en
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/?term=sreeja+narayanan